Pembrolizumab and Daratumumab indication broadening dates and dosages

Name: Pembrolizumab and Daratumumab indication broadening dates and dosages
Published: 2023-09-28T08:31:04+00:00
License: https://creativecommons.org/licenses/by/4.0/
Keywords: CBP model, pembrolizumab, daratumumab

dataset

posted on 2023-09-28, 08:31 authored by Renaud HeineRenaud Heine

This data set contains data on indication broadening dates and dosages for pembrolizumab and daratumumab.

History

Usage metrics

Keywords

CBP model pembrolizumab daratumumab

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM